This bill amends the Energy Policy Act of 2005 to create a new program at the Department of Energy that funds and operates precommercial bioindustrial technology maturation facilities. The facilities are intended to be open-access user sites where industry, academia, and government can run pilot and early manufacturing demonstrations that bridge laboratory prototypes to commercial scale.
The measure leans on a federal role to reduce the principal commercialization barrier for biotechnology—scaling—by providing shared infrastructure, digital data exchange, workforce training, and coordinated planning across federal agencies and regional partners. It also sets parameters for intellectual property, reporting, and coordination with the defense and agricultural communities so the facilities can target energy and supply‑chain resilience use cases.
At a Glance
What It Does
Requires the Secretary of Energy to establish not fewer than two bioindustrial technology maturation 'covered facilities' that operate as precommercial user facilities, with a focus on pilot testing, scale-up, digital infrastructure, and workforce development. The statute adds a set of definitions (e.g., bioindustrial manufacturing, biointermediate, technology maturation) to guide program scope.
Who It Affects
Early‑stage biotechnology companies, biomanufacturers, National Laboratories, agricultural feedstock suppliers, the defense industrial base, and regional workforce and economic development actors who will use or host the facilities. DOE will be the implementing agency and coordinate with Commerce, Defense, Agriculture, and other partners.
Why It Matters
The bill creates a federal shared‑infrastructure pathway to lower the cost and risk of scaling non‑pharmaceutical bioproducts, potentially unlocking private investment and diversifying supply chains. It also sets expectations for open access, data sharing, IP treatment for Federal employees, and a coordinated strategic plan that will shape where and how the facilities are built.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a batch of definitions to the Energy Policy Act of 2005 to clarify what counts as bioindustrial manufacturing, biointermediates, technology maturation, open access, and waste streams. Those definitions set the perimeter for what the new facilities should target—nonpharmaceutical biological production, conversion of biomass or waste into intermediates and products, and maturation activities such as pilot runs, prototyping, and early‑stage manufacturing.
It requires the Department of Energy to stand up at least two 'covered facilities'—precommercial, open‑access user facilities—by a statutory deadline. The Secretary must plan facilities that are geographically distributed, complementary to existing infrastructure (including National Laboratories and other federal programs), and able to operate together as a connected network to cover a wide range of fermentation and bioprocessing needs.
The bill emphasizes that the first facility should be planned and built within a two‑year time period and that subsequent facilities be planned while earlier construction proceeds.The statute enumerates an operational menu for those facilities: pilot and demonstration projects for customers, scale‑up services to reach higher production levels, technology and equipment development, resolving feedstock and waste‑stream conversion challenges, workforce training, and building interoperable digital systems for secure data exchange. It explicitly tasks covered facilities with developing cybersecurity, process assurance, modeling and techno‑economic analysis, and other tools that help customers make investment decisions.To guide implementation the Secretary must publish a request for information within 90 days and deliver a strategic plan to Congress within 180 days.
The plan must assess capacity needs, describe the type, size, location and number of facilities, timeline phases, the equipment focus for each site, how the sites will function as a network, and coordination with other agencies (including Commerce and Defense). The bill sets IP rules that put intellectual property generated by Federal employees at these facilities into the public domain while allowing private actors to retain IP subject to contractual terms.
It also creates an annual reporting requirement for eight years and authorizes appropriations for implementation across fiscal years 2026–2030.
The Five Things You Need to Know
The bill requires the Department of Energy to establish not fewer than two bioindustrial technology maturation 'covered facilities' as precommercial, open‑access user facilities.
The first covered facility must be planned and built within a two‑year time period, and subsequent facilities must be planned contemporaneously with earlier construction.
The Secretary must publish a request for information within 90 days and submit a strategic plan to relevant congressional committees within 180 days of enactment.
Intellectual property created by Federal employees at the covered facilities is placed in the public domain; non‑Federal contributors' IP is governed by contractual agreements.
Congress authorizes $225,500,000 for the program for fiscal years 2026 through 2030 to fund establishment and operation of the facilities.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
New statutory definitions that set program scope
The bill inserts a set of targeted definitions—such as 'bioindustrial manufacturing,' 'biointermediate,' 'technology maturation,' 'open access,' 'phytobiome,' and an expansive 'waste stream' definition—into section 932(a) of the Energy Policy Act. Those definitions delimit the program to non‑pharmaceutical biological production, include a wide range of feedstocks (from municipal waste to industrial gases), and require the program to prioritize open access where feasible. Practically, these definitions determine what projects the facilities may host and which value chains the program will serve.
Mandate to establish covered facilities and permissible activities
Subsection (f)(1) mandates establishment of not fewer than two covered facilities by September 30, 2030, and requires them to operate as user facilities available to public and private entities. Subsection (f)(3) lists the operational activities permitted at covered facilities—pilot and demonstration projects, scale‑up support, equipment and software development, feedstock conversion research, workforce training, and building secure, interoperable digital infrastructure—giving DOE explicit authority to house both physical and digital scale‑up capabilities.
Location, timing and network design considerations
The statute obliges the Secretary to consider industry needs and gaps, unique capabilities not available elsewhere, and how facilities will complement DOE labs and other federal programs. It requires geographic diversity to align inputs, workforce, and local infrastructure, and directs the program to plan for facilities that operate as a network—ensuring, for example, that available fermentation capacity across sites covers the spectrum of precommercial needs. The text also requires the first facility to be planned and constructed within two years, signaling a rapid initial deployment.
Collaboration, RFI, and strategic plan requirements
Covered facilities are authorized to adopt open‑access policies, pursue cost‑sharing arrangements, and coordinate with a long list of partners—industry, National Laboratories, DoD (including BioMADE), USDA, DOT, Commerce, academic institutions, rural stakeholders, and international scientific bodies. The Secretary must issue an RFI within 90 days to gather data on existing and planned facilities and best practices, then produce a strategic plan within 180 days that spells out capacity needs, the planned number and location of facilities, timelines, equipment focus, networking mechanics, data sharing approaches, and interagency coordination.
IP regime, reporting cadence, and authorization of funds
The bill sets a distinct IP framework: inventions or IP created by Federal employees at covered facilities fall into the public domain, while IP from non‑Federal individuals is subject to normal IP laws and contractual terms. It requires an annual public report to Congress for eight years detailing the number and activities of covered facilities, planned expansions, and collaborations. Finally, the statute includes an explicit authorization of $225,500,000 for fiscal years 2026–2030 to carry out the subsection, establishing a funding baseline without dictating appropriation timing or exact allocations.
This bill is one of many.
Codify tracks hundreds of bills on Energy across all five countries.
Explore Energy in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Early‑stage biotechnology companies: Gain access to pilot‑scale and precommercial facilities they could not afford on their own, lowering the technical and capital risk of scaling non‑pharmaceutical bioproducts.
- Feedstock suppliers and agricultural producers: Create demand for biomass, waste streams, and biointermediates by expanding domestic processing pathways and new markets for agricultural residues.
- Regional and rural economies: Stand to benefit from geographic placement requirements, workforce training programs, and job creation tied to facility construction and operations.
- Department of Energy and National Laboratories: Can leverage existing capabilities to move technologies closer to commercialization, strengthening the translational pipeline and federal influence over standards and interoperability.
- Defense and critical infrastructure sectors: Gain an additional domestic avenue to secure resilient, biobased supply chains and partner on relevant scale‑up projects through explicit coordination provisions.
Who Bears the Cost
- Department of Energy: Responsible for planning, building, operating, staffing, and coordinating the covered facilities, including developing digital systems and cybersecurity protections.
- Taxpayers: The program is backed by a multi‑year authorization of appropriations; actual costs depend on future appropriations and any cost‑sharing arrangements with industry.
- Private partners and contractors: Expected to enter into contractual arrangements that may require cost‑sharing, data sharing, and acceptance of facility terms, which can impose compliance and commercial costs.
- Universities and research institutions: When participating, they may need to negotiate IP and data terms, align curricula to workforce needs, and contribute to collaborative projects under facility rules.
- Existing commercial biomanufacturers: Face potential competitive pressure from subsidized public infrastructure and must decide whether to engage under open‑access terms or continue private investments.
Key Issues
The Core Tension
The bill seeks to lower private scale‑up risk by offering publicly funded, open‑access infrastructure and data systems, but doing so risks reducing private incentives to invest in proprietary scale‑up capacity and may complicate IP and commercialization models—forcing a choice between maximizing public access to spur broad innovation and protecting commercial incentives necessary to attract private capital.
The bill threads together public‑interest aims—open access, regional inclusion, and shared digital infrastructure—with the realities of capital‑intensive, commercially driven biomanufacturing. A central implementation challenge will be translating high‑level statutory language into operational agreements that balance openness with commercial confidentiality.
The statutory requirement that Federal employee‑created IP reside in the public domain may speed diffusion of techniques but could discourage some private actors from bringing proprietary processes to a covered facility unless contracts offer compensating commercial protections.
Another practical tension is funding and sustainability. The authorized $225.5 million over five years provides a federal down‑payment but will likely be insufficient to build and operate multiple large‑scale pilot production sites and sustain advanced digital platforms long term.
The statute anticipates cost‑sharing and partnerships, but designing stable financing models without privileging large incumbents or creating de facto subsidies that crowd out private investment will require careful policy design. Finally, the bill's broad collaboration list and emphasis on interoperable data exchange raise governance questions about who sets data standards, how sensitive information (including dual‑use capabilities) is protected, and how coordination across DOE, DOD, USDA, Commerce, and state actors will be operationalized.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.